Narayan Prabhu's most recent trade in Reviva Pharmaceuticals Holdings Inc. was a trade of 194,250 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reviva Pharmaceuticals Hol... | Narayan Prabhu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 194,250 | 194,250 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Narayan Prabhu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2024 | 96,519 | 96,519 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Narayan Prabhu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 170,000 | 170,000 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Narayan Prabhu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.66 per share. | 30 Sep 2022 | 50,000 | 100,000 | - | 1.7 | 83,000 | Common Stock, par value $0.0001 per share |
| Reviva Pharmaceuticals Hol... | Narayan Prabhu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 30 Jun 2022 | 50,000 | 50,000 | - | 1.2 | 60,670 | Common Stock, par value $0.0001 per share |
| Reviva Pharmaceuticals Hol... | Narayan Prabhu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |